Surgery is about to change with the introduction of a new surgical robotic system at the University of Calgary/Calgary Health Region. NeuroArm aims to revolutionize neurosurgery and other branches of operative medicine by liberating them from the constraints of the human hand.
Researchers concluded that the synergistic combination of Reolysin and gemcitabine is a promising therapeutic regimen for study in clinical trials.
AARP announced an expanded and innovative relationship with UnitedHealth Group and a new relationship with Aetna, to help provide unique health insurance plans designed to meet the needs of AARP’s diverse 38 million members and others 50+.
As US Congress prepares to vote on the most significant prescription drug safety legislation in 45 years, a new Consumer Reports poll finds that the American public strongly backs a host of key safety reforms.
deCODE genetics, Inc. (Nasdaq:DCGN) announced the launch of deCODE T2?, a novel DNA-based reference laboratory test for the first common and well-validated genetic risk factor for type 2 diabetes (T2D).
AARP will be sending the following letter from CEO Bill Novelli to every member of the U.S. Senate alerting them that the association will be recording the upcoming Senate vote on a bill to allow Medicare to negotiate for lower prescription drug prices.
The Medical Institute responded to the “Impact of Four Title V, Section 510 Abstinence Education Programs” final report released earlier by Mathematica Policy Research Inc., affirming that the report did not call for de-funding of abstinence programs but simply advocated further study.
AARP CEO Bill Novelli released the following statement today after the U.S. Senate Finance Committee passed a bill to give Medicare the power to bargain for lower drug prices (S. 3) with a bipartisan vote.
The Heart and Stroke Foundation (HSF) joined Toronto Public Health to release two new reports and urge the federal government to eliminate deadly processed trans fats in our food supply.
The Robert Wood Johnson Foundation (RWJF) announced it will commit at least $500 million over the next five years to tackle one of the most urgent public health threats facing our nation: childhood obesity.